Your browser doesn't support javascript.
loading
The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy.
Hao, Jiaojiao; Xu, Hua; Luo, Meihua; Yu, Wendan; Chen, Miao; Liao, Yina; Zhang, Changlin; Zhao, Xinrui; Jiang, Wei; Hou, Shuai; Feng, Xu; Zou, Kun; Chen, Yiming; Huang, Wenlin; Guo, Wei; Kang, Lan; Deng, Wuguo.
Afiliación
  • Hao J; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Xu H; Department of Gynaecology, Hospital of China Medical University, Number 202 Hospital of China PLA (People's Liberation Army), Shenyang, China.
  • Luo M; Shunde Hospital, Southern Medical University, Foshan, China.
  • Yu W; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Chen M; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Liao Y; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zhang C; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Zhao X; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Jiang W; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Hou S; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Feng X; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zou K; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Chen Y; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Huang W; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China; State Key Laboratory of Targeted Drug for Tumors of Guangdong Province, Guangzhou Double Bioproduct, Incorporated, Guangzhou, China.
  • Guo W; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China. Electronic address: wei1015@dmu.edu.cn.
  • Kang L; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China. Electronic address: kanglan@dlmedu.edu.cn.
  • Deng W; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China. Electronic address: dengwg@sysucc.org.cn.
J Invest Dermatol ; 138(1): 159-170, 2018 01.
Article en En | MEDLINE | ID: mdl-28899685
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Factores de Transcripción / Regulación Neoplásica de la Expresión Génica / Ciclooxigenasa 2 / Óxido Nítrico Sintasa de Tipo II / Melanoma Tipo de estudio: Prognostic_studies Idioma: En Revista: J Invest Dermatol Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Factores de Transcripción / Regulación Neoplásica de la Expresión Génica / Ciclooxigenasa 2 / Óxido Nítrico Sintasa de Tipo II / Melanoma Tipo de estudio: Prognostic_studies Idioma: En Revista: J Invest Dermatol Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos